共 6 条
- [4] C-Terminal Provasopressin (Copeptin) is Associated With Left Ventricular Dysfunction, Remodeling, and Clinical Heart Failure in Survivors of Myocardial Infarction[J] . Dominic Kelly,Iain B. Squire,Sohail Q. Khan,Paulene Quinn,Joachim Struck,Nils G. Morgenthaler,Joan E. Davies,Leong L. NG.Journal of Cardiac Failure . 2008 (9)
- [5] National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure[J] . W H. Wilson Tang,Gary S. Francis,David A. Morrow,L Kristin Newby,Christopher P. Cannon,Robert L. Jesse,Alan B. Storrow,Robert H. Christenson,Robert H. Christenson,Fred S. Apple,Christopher P. Cannon,Gary S. Francis,Robert L. Jesse,David A. Morrow,L Kristin Newby,Jan Ravkilde,Alan B. Storrow,W H. Wilson Tang,Alan H.B. Wu.Circulation . 2007 (5)
- [6] C-Terminal Provasopressin (Copeptin) as a Novel and Prognostic Marker in Acute Myocardial Infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study[J] . Sohail Q. Khan,Onkar S. Dhillon,Russell J. O’Brien,Joachim Struck,Paulene A. Quinn,Nils G. Morgenthaler,Iain B. Squire,Joan E. Davies,Andreas Bergmann,Leong L. Ng.Circulation . 2007 (16)